SARS-CoV2 infects respiratory epithelial cells via its cellular receptor angiotensin-
converting enzyme 2, causing a viral pneumonia with pronounced inflammation resulting in …

The lung is the primary site of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2)-induced immunopathology whereby the virus enters the host cells by binding to …

Currently available vaccines against severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) are highly effective but not able to keep the coronavirus disease 2019 …

The coronavirus disease 2019 (COVID-19), is a highly contagious transmittable disease
caused by a recently discovered coronavirus, pathogenic SARS-CoV-2. Followed by the …

The number of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected
patients keeps rising in most of the European countries despite the pandemic precaution …

The COVID‐19 pandemic caused by SARS‐Cov‐2 demands rapid, safe and effective
therapeutic options. In the last decades, the endogenous gasotransmitter hydrogen sulfide …

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) generated a
worldwide emergency, until the declaration of the pandemic in March 2020. SARS-CoV-2 …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has
significantly impacted the world and has driven many researchers into the pathophysiology …

Background: SARS-CoV-2 infection can cause renal involvement, and severe renal
dysfunction is more common among patients with chronic comorbid conditions, especially …

As of August 6th, 2021, the World Health Organization has notified 200.8 million laboratory-
confirmed infections and 4.26 million deaths from COVID-19, making it the worst pandemic …